Skip to main navigation Skip to search Skip to main content

The GR-LEDGF/p75-HSP27 Axis Contributes to Cross-Resistance Between Enzalutamide and Docetaxel in Prostate Cancer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1566
JournalCells
Volume14
Issue number19
DOIs
StatePublished - Oct 2025

ASJC Scopus Subject Areas

  • General Biochemistry,Genetics and Molecular Biology

Keywords

  • HSP27
  • LEDGF/p75
  • RNA sequencing
  • docetaxel
  • drug cross-resistance
  • enzalutamide
  • glucocorticoid receptor
  • prostate cancer
  • Receptors, Glucocorticoid/metabolism
  • Nitriles/pharmacology
  • Humans
  • Male
  • Heat-Shock Proteins
  • HSP27 Heat-Shock Proteins/metabolism
  • Drug Resistance, Neoplasm/drug effects
  • Benzamides/pharmacology
  • Gene Expression Regulation, Neoplastic/drug effects
  • Signal Transduction/drug effects
  • Adaptor Proteins, Signal Transducing/metabolism
  • Animals
  • Cell Line, Tumor
  • Molecular Chaperones/metabolism
  • Prostatic Neoplasms/drug therapy
  • Mice
  • Phenylthiohydantoin/pharmacology
  • Docetaxel/pharmacology

Cite this